Author

Xin Liu

Chinese Academy of SciencesORCID 0000-0002-8843-9610Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xin Liu15 papers · BGI Group (China)

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

Xiu‐Jie WangiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

1 paper

Recent·Most cited

BioinformaticsJournal of genetics and genomics/Journal of Genetics and GenomicsPeer-reviewedFeb 1, 2020

Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines

Xin Liu, Xiu‐Jie Wang

The paper identifies 10 commercial medicines that may inhibit 2019-nCoV Mpro by forming hydrogen bonds with key residues in its binding pocket, potentially offering higher mutation tolerance than lopinavir/ritonavir.

464 citationstop 1%

virusstatistical model

𝕏 PostBluesky